āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āφāϏāϛ⧇

āĻ¸ā§āĻŦāϝāĻŧāĻ‚āĻ•ā§āϰāĻŋāϝāĻŧ āϚāĻžāϞ⧁

Wermer Syndrome (MEN Type 1) Multiple endocrine neoplasia

1 āĻ­āĻŋāω â€ĸ 07/10/23
āĻļ⧇āϝāĻŧāĻžāϰ āĻ•āϰ⧁āύ
āĻŦāϏāĻžāύ
administrator
administrator
āϏāĻžāĻŦāĻ¸ā§āĻ•ā§āϰāĻžāχāĻŦāĻžāϰ
0

📌 𝐅𝐨đĨđĨ𝐨𝐰 𝐨𝐧 𝐈𝐧đŦ𝐭𝐚𝐠đĢ𝐚đĻ:- https://www.instagram.com/drgbhanuprakash
📌𝗝đ—ŧđ—ļđ—ģ đ—ĸ𝘂đ—ŋ 𝗧𝗲𝗹𝗲𝗴đ—ŋ𝗮đ—ē 𝗖đ—ĩ𝗮đ—ģđ—ģ𝗲𝗹 𝗛𝗲đ—ŋ𝗲:- https://t.me/bhanuprakashdr
📌đ—Ļđ˜‚đ—¯đ˜€đ—°đ—ŋđ—ļđ—¯đ—˛ 𝗧đ—ŧ 𝗠𝘆 𝗠𝗮đ—ļ𝗹đ—ļđ—ģ𝗴 𝗟đ—ļ𝘀𝘁:- https://linktr.ee/DrGBhanuprakash

Wermer Syndrome (MEN Type 1) Multiple endocrine neoplasia

Multiple endocrine neoplasia (MEN) syndromes consist of 2 categories, MEN type 1 (MEN1) and MEN type 2 (MEN2). MEN2 has been subcategorized into MEN2-A, MEN2-B, and medullary thyroid cancer (MTC)–only.
The combination of parathyroid tumors, pancreatic islet cell tumors, and anterior pituitary tumors (see the images below) is characteristic of MEN1. Although usually inherited as an autosomal dominant disorder, MEN1 can also occur sporadically (without a family history) as a result of new mutations. It is also important to keep in mind that family members of an MEN1-affected individual may have been undiagnosed at the time of death. Patients with untreated MEN1 have a decreased life expectancy, with a 50% probability of death by age 50 years.

āφāϰ⧋ āĻĻ⧇āϖ⧁āύ
0 āĻŽāĻ¨ā§āϤāĻŦā§āϝ sort āĻ•ā§āϰāĻŽāĻžāύ⧁āϏāĻžāϰ
āĻĢ⧇āϏāĻŦ⧁āĻ• āĻŽāĻ¨ā§āϤāĻŦā§āϝ

āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āφāϏāϛ⧇

āĻ¸ā§āĻŦāϝāĻŧāĻ‚āĻ•ā§āϰāĻŋāϝāĻŧ āϚāĻžāϞ⧁